The global hormone replacement therapy (HRT) market is on the rise, projected to reach a value of USD 21.28 billion in 2022 and is expected to grow at a steady 6.6% CAGR from 2023 to 2030. This growth is primarily driven by the increasing prevalence of target diseases and the availability of long-lasting hGH products.   Thyroid disorders, for instance, affect a significant...